NEW YORK (
was downgraded to hold at TheStreet Ratings.
was downgraded at UBS to neutral following the merger announcement with
Mid-America Apartment Communities
(CME - Get Report)
was upgraded at Wells Fargo to outperform from market perform. Estimates were also boosted, given higher volumes, Wells Fargo said. Company has earnings potential of $5 a share.
(EBAY - Get Report)
was upgraded at Compass Point to buy from neutral. $63 price target. Company is positioned well to benefit from the shift away from traditional retail, Compass Point said.
was upgraded at UBS to neutral. The discounted valuation and 4.5% dividend yield provide downside support, UBS said. Price target is increased to $63.
was downgraded to sell at TheStreet Ratings.
Stock Comments / EPS Changes
price target was raised at Jefferies to $18. Company is gaining market share, Jefferies said. Buy rating.
price target was boosted at Jefferies to $36. Industry production is growing, Jefferies said. Hold rating.
price target was raised at BMO Capital to $54. Company has an exciting clinical pipeline, BMO Capital said. Outperform rating.
price target and estimates were cut at UBS. Earnings estimates were reduced to reflect the announced workforce rationalization, UBS said. Price target is reduced to $3.30.
>To submit a news tip, email:
and become a fan on